Nagano Hiroyuki, Tomori Koji, Koiwa Mano, Kobayashi Shotaro, Takahashi Masahiro, Makabe Hideki, Okada Hirokazu, Kushiyama Akifumi
Department of Pharmacy, Saitama Medical University Hospital, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
Department of Pharmacotherapy, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose-shi, Tokyo 204-8588, Japan.
Pharmacy (Basel). 2023 Feb 23;11(2):43. doi: 10.3390/pharmacy11020043.
We investigated the relationship between multidrug administration and the characteristics, pathophysiology, and drug class in outpatients with hemodialysis. A retrospective cross-sectional study was conducted at Saitama Medical University Hospital in October 2018. Multidrug administration was defined as receiving either more than six drugs or more than the median number of drugs. The drugs used were represented by their anatomical classification codes in the Anatomical Therapeutic Chemistry Classification System (ATC classification). A latent class analysis (LCA) was used to identify clusters at risk of receiving multiple medications. A stepwise logistic regression analysis was performed to select ATC classifications prone to being involved in multidrug administration. As of October 2018, 98 outpatients with hemodialysis were enrolled in the study. In the LCA, when diabetes was the main primary disease, oral hypoglycemic agents available to dialysis patients were limited, but the number of drugs administered was large. Old age, poor nourishment, a long history of dialysis, and chronic nephritis were associated with multidrug administration among nondiabetic patients. In the second level of the ATC classification, the drugs frequently used were coded A02 (drugs for acid-related disorders), A07 (antidiarrheal agents, intestinal anti-inflammatory/anti-infective agents), B01 (antithrombotic agents), and N05 (psycholeptics). The prescribing patterns for either diabetic patients or nondiabetic elderly patients were identified in outpatients with hemodialysis taking multiple medications, and drugs for acid-related disorders, antidiarrheal agents, intestinal anti-inflammatory/anti-infective agents, antithrombotic agents, and psycholeptics are frequently used in those patients.
我们研究了血液透析门诊患者多药联用与药物特性、病理生理学及药物类别之间的关系。2018年10月在埼玉医科大学医院进行了一项回顾性横断面研究。多药联用定义为服用超过六种药物或超过药物中位数数量。所使用的药物通过解剖治疗化学分类系统(ATC分类)中的解剖学分类代码表示。采用潜在类别分析(LCA)来识别接受多种药物治疗风险的聚类。进行逐步逻辑回归分析以选择易于参与多药联用的ATC分类。截至2018年10月,98例血液透析门诊患者纳入研究。在LCA中,当糖尿病为主要原发性疾病时,透析患者可用的口服降糖药有限,但给药数量较多。在非糖尿病患者中,老年、营养不良、透析病史长和慢性肾炎与多药联用有关。在ATC分类的第二级中,常用药物编码为A02(与酸相关疾病的药物)、A07(止泻药、肠道抗炎/抗感染药)、B01(抗血栓药)和N05(抗精神病药)。在服用多种药物的血液透析门诊患者中确定了糖尿病患者或非糖尿病老年患者的处方模式,并且这些患者经常使用与酸相关疾病的药物、止泻药、肠道抗炎/抗感染药、抗血栓药和抗精神病药。